We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
-2.82%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$20.3B
AUM Growth
-$365M
Cap. Flow
+$648M
Cap. Flow %
3.19%
Top 10 Hldgs %
26.97%
Holding
2,921
New
57
Increased
957
Reduced
718
Closed
195

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$81.9M
2
CSCO icon
Cisco
CSCO
+$60.5M
3
ATKR icon
Atkore
ATKR
+$43M
4
BNS icon
Scotiabank
BNS
+$40.3M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$38M

Top Sells

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$50.9M
2
SIVB
SVB Financial Group
SIVB
+$35.9M
3
TMUS icon
T-Mobile US
TMUS
+$33.6M
4
APTV icon
Aptiv
APTV
+$28M
5
XLNX
Xilinx Inc
XLNX
+$26.9M

Sector Composition

Rank Sector Weight
1 Technology 25.3%
2 Financials 15.57%
3 Healthcare 14.62%
4 Consumer Discretionary 10.14%
5 Industrials 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTG icon
2576
Pennant Group
PNTG
$1.33B
$28K ﹤0.01%
1,516
PRTS icon
2577
CarParts.com
PRTS
$51.3M
$28K ﹤0.01%
417
TALO icon
2578
Talos Energy
TALO
$2.6B
$28K ﹤0.01%
1,767
UEIC icon
2579
Universal Electronics
UEIC
$74.6M
$28K ﹤0.01%
908
XERS icon
2580
Xeris Biopharma Holdings
XERS
$1.53B
$28K ﹤0.01%
+10,751
New +$26.3K
AMRX icon
2581
Amneal Pharmaceuticals
AMRX
$5.46B
$27K ﹤0.01%
6,588
-17
-0.3% -$75
ANIK icon
2582
Anika Therapeutics
ANIK
$284M
$27K ﹤0.01%
1,073
ATNI icon
2583
ATN International
ATNI
$481M
$27K ﹤0.01%
671
COGT icon
2584
Cogent Biosciences
COGT
$6.61B
$27K ﹤0.01%
+3,612
New +$25.2K
KMDA icon
2585
Kamada
KMDA
$409M
$27K ﹤0.01%
+4,755
New +$28.5K
LXRX icon
2586
Lexicon Pharmaceuticals
LXRX
$1.08B
$27K ﹤0.01%
12,688
ZYME icon
2587
Zymeworks
ZYME
$1.73B
$27K ﹤0.01%
4,097
ZYXI
2588
DELISTED
Zynex
ZYXI
$27K ﹤0.01%
4,330
LBC
2589
DELISTED
Luther Burbank Corporation Common Stock
LBC
$27K ﹤0.01%
2,037
BLU
2590
DELISTED
BELLUS Health Inc.
BLU
$27K ﹤0.01%
+3,904
New +$25.1K
TCDA
2591
DELISTED
Tricida, Inc. Common Stock
TCDA
$27K ﹤0.01%
3,270
+1,569
+92% +$14.2K
AVDL
2592
DELISTED
Avadel Pharmaceuticals
AVDL
$26K ﹤0.01%
+3,836
New +$26.4K
DX
2593
Dynex Capital
DX
$3.21B
$26K ﹤0.01%
1,619
EVER icon
2594
EverQuote
EVER
$884M
$26K ﹤0.01%
1,594
JNCE
2595
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$26K ﹤0.01%
+3,819
New +$27.2K
CLVS
2596
DELISTED
Clovis Oncology, Inc.
CLVS
$26K ﹤0.01%
13,111
AVIR icon
2597
Atea Pharmaceuticals
AVIR
$404M
$25K ﹤0.01%
3,469
FF icon
2598
Future Fuel
FF
$279M
$25K ﹤0.01%
2,541
INSG icon
2599
Inseego
INSG
$84.9M
$25K ﹤0.01%
629
ABUS icon
2600
Arbutus Biopharma
ABUS
$923M
$24K ﹤0.01%
+8,108
New +$24.8K

Similar funds

Zurich Cantonal Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Zurich Cantonal Bank held 2,921 positions worth $20.3B, down 1.8% from $20.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Zurich Cantonal Bank deployed $648M of net new capital in Q1 2022, opening 57 new positions and adding to 957 existing holdings. Its largest new stake was Amplify Travel Tech ETF: 21,900 shares worth $523K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was UBS Group, an estimated $50.9M trimmed.

  • Zurich Cantonal Bank's largest Q1 2022 buy was Amplify Travel Tech ETF: 21,900 shares worth $523K.
  • Zurich Cantonal Bank added most to Verizon in Q1 2022, an estimated $81.9M increase.
  • Zurich Cantonal Bank's biggest Q1 2022 reduction was UBS Group, cutting an estimated $50.9M.
  • Zurich Cantonal Bank fully exited Xilinx Inc in Q1 2022, selling an estimated $26.9M.
  • Zurich Cantonal Bank's ten largest holdings make up 27% of its $20.3B portfolio in Q1 2022.
  • Zurich Cantonal Bank opened 57 new positions and closed 195 in Q1 2022.
  • Zurich Cantonal Bank's portfolio value fell 1.8% quarter-over-quarter to $20.3B.

Based on Zurich Cantonal Bank's 13F filing for Q1 2022, filed 21 Apr 2022.